Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Consolidated Statements of Operations
Product revenue, net	$ 22,733	$ 24,199	$ 76,667	$ 69,221
Revenue from Contract with Customer, Product and Service	Product	Product	Product	Product
Cost of sales	$ 9,990	$ 11,513	$ 28,599	$ 31,780
Gross profit	12,743	12,686	48,068	37,441
Operating expenses
Research and development	856	3,282	3,630	9,409
Selling and marketing	12,804	9,743	33,466	28,700
General and administrative	7,177	7,616	22,517	23,785
Gain from contingent consideration	(734)	(1,234)	(504)	(682)
Impairment expense		45,196	2,600	64,649
Amortization of intangible assets	1,198	1,504	3,593	4,546
Total operating expenses	21,301	66,107	65,302	130,407
Loss from operations	(8,558)	(53,421)	(17,234)	(92,966)
Other income (expense)
Other (expense) income, net	(1,215)	(32)	(3,527)	4
Gain on extinguishment of debt		169		169
Gain (loss) on derivative warrant liabilities	2,573	(7)	6,167	(7)
Total other income (expense)	1,358	130	2,640	166
Loss before income tax	(7,200)	(53,291)	(14,594)	(92,800)
Income tax benefit				(110)
Net loss	$ (7,200)	$ (53,291)	$ (14,594)	$ (92,690)
Weighted average number of common shares outstanding - basic (in shares)	3,726,779	1,484,492	3,099,130	1,360,585
Weighted average number of common shares outstanding - diluted (in shares)	3,726,779	1,484,492	3,099,130	1,360,585
Basic net loss per common share (in dollars per share)	$ (1.93)	$ (35.90)	$ (4.71)	$ (68.13)
Diluted net loss per common share (in dollars per share)	$ (1.93)	$ (35.90)	$ (4.71)	$ (68.13)